Vasospastic angina pectoris complicated by ventricular fibrillation during treatment with propranolol and labetalol
Krug, H.; Poprawski, K.; Ochotny, R.
Kardiologia Polska 26(1): 71-77
1983
ISSN/ISBN: 0022-9032 PMID: 6876536 Document Number: 217727
Document emailed within 1 workday
Related Documents
Iso, Y.; Takeyama, Y. 2011: Prognostic evidences of chronic stable angina pectoris, vasospastic angina and microvascular angina Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 9): 28-33Kanto, J.H. 1987: Labetalol in the treatment of angina pectoris International Journal of Clinical Pharmacology Therapy and Toxicology 25(3): 166-174
Nielsen, H. 1987: Vasospastic angina pectoris Ugeskrift for Laeger 149(19): 1239-1242
Lindhardt, T.B.; Walker, L.R.; Colov, N.S.; Hansen, P.S. 2000: Vasospastic angina pectoris following abortion induced by prostaglandin analogue Ugeskrift for Laeger 162(48): 6536-6537
Broustet, J.P.; Cherrier, J.F.; Pic, A. 1985: Trial of labetalol in effort angina pectoris Annales de Cardiologie et d'Angeiologie 34(3): 171-176
Mezhetskaia, I.A.; Shalaev, S.V.; Safiullina, Z.M.; Baranova, T.A.; Zhmurov, V.A. 1992: Significance of platelet membrane destruction in vasospastic angina pectoris during its exacerbation Kardiologiia 32(5): 72-75
Matthesen, T.; Olsen, R.H.; Bosselmann, H.S.; Lidegaard, Øj. 2017: Cardiac arrest induced by vasospastic angina pectoris after vaginally administered misoprostol Ugeskrift for Laeger 179(26)
Masuda, T.; Yamakado, T.; Nakano, T. 1994: Analysis of malignant ventricular arrhythmias during attack of vasospastic angina Nihon Rinsho. Japanese Journal of Clinical Medicine 52 Suppl (Part 2): 270-273
Kaikita, K.; Ogawa, H. 2011: Criteria for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 9): 53-58
Chaĭtington DzhR; Refteri, E.B. 1980: Clinical trial of oxyfedrine and propranolol in angina pectoris Terapevticheskii Arkhiv 52(5): 59-62
Lumholtz, I.B. 1980: Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 10th and last part. 4. other angina pectoris agents Sygeplejersken 80(20): 23
Ilyas, M.; Jafary, M.H.; Peracha, M.A.; Janjua, M.; Khan, N. 1975: Double blind trial of propranolol and pindolol in angina pectoris Jpma. Journal of the Pakistan Medical Association 25(7): 165-166
Sagar, S.; Pandhi, P.; Anand, I.S.; Sharma, P.L.; Wahi, P.L. 1985: Double-blind crossover clinical trial of oxyfedrine and propranolol in angina pectoris International Journal of Clinical Pharmacology Therapy and Toxicology 23(4): 186-189
Asenjo, R.; Corbalán, R.; Casanegra, P.; Chamorro, G.; Valenzuela, P. 1987: Comparative effects of diltiazem and nifedipine combined with propranolol, in patients with chronic stable angina pectoris Revista Medica de Chile 115(6): 512-517
De Ponti, C.; Mauri, F.; Ciliberto, G.R.; Caru, B. 1980: Comparative effects of nifedipine, verapamil, isosorbide dinitrate and propranolol on exercise-induced angina pectoris British Journal of Clinical Practice. Suppl 8: 53-58
Karpov, I.A.; Gratsianskiĭ, N.A.; Maevskaia, E.G. 1983: Unstable angina pectoris: diastolic pressure in the pulmonary artery, cardiac index and acute hemodynamic effect of propranolol Kardiologiia 23(6): 112-114
Nedok, A.; Curcić, V. 1972: Prinzmetal's variant of spontaneous angina pectoris (angina pectoris inversa). Report of 3 cases Srpski Arhiv Za Celokupno Lekarstvo 100(2): 193-209
Minatoguchi, S. 2011: Treatment and prognosis of vasospastic angina Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 9): 64-69
Kijima, M. 2003: Treatment and prognosis of vasospastic angina Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 5): 159-166
Harvald, B. 1980: Comparison of labetalol and propranolol in treatment of hypertension Postgraduate Medical Journal 56(Suppl 2): 65-68